🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSOUL trial preliminary data — 6 month update

SOUL trial preliminary data — 6 month update

pete_RVA Fri, Aug 1, 2025 at 8:34 PM 9 replies 1,081 viewsPage 1 of 2
This thread is more than 7 months old. Information may be outdated. Consider searching for more recent discussions.
pete_RVA
Member
178
890
Dec 2024
Richmond, VA
Aug 1, 2025 at 9:59 PM#1

Hey everyone. I have been on semaglutide for 3 months now and wanted to get the community's take on something.

SOUL trial preliminary data — 6 month update

I have been reading through old threads but have not found exactly what I'm looking for. My situation: my doctor suggested soul trial preliminary data 6 month and I am not sure what to make of it.

Has anyone else dealt with this? What was your experience? My endo was not super helpful — just said to "monitor it" which is not exactly actionable advice lol.

Any input appreciated. Thanks in advance. 🙏

10 2mike_mod, SarahChen_PharmD, sarah.morrison and 7 others
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Aug 1, 2025 at 10:16 PM#2

SOUL trial preliminary data 6 month — I actually dealt with this exact situation a few weeks ago.

Short answer: it depends on your starting point. Longer answer: I wrote about my experience in the dosing forum if you want the full details.

Last edited: Aug 1, 2025 at 11:16 PM
25 12roxy_nash, tony_orlando, Dr.NephBHM_UK and 22 others
Reply Quote Save Share Report
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Aug 1, 2025 at 10:33 PM#3
sarah.morrison said:
Short answer: it depends on your starting point

Completely agree with sarah.morrison. I would add that SOUL trial preliminary data 6 also has implications for long-term metabolic health that sometimes get overlooked in these discussions.

In my case, following a similar approach led to significant improvements compared to what I was doing before.

10 5CanadaChris, ZaraB_AL, JakeSmashed95 and 7 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
JenPlateau
Member
234
890
Nov 2024
Missouri
Aug 1, 2025 at 10:50 PM#4

This thread is incredible for SOUL trial prelimina info. Better than most online groups.

45 2FitDadDave, RunnerRach, TrialNerd_Beth and 42 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Aug 1, 2025 at 11:07 PM#5

As a pharmacist, I want to add some clinical context to this discussion on SOUL trial preliminary data 6 month.

Building on what pete_RVA said — the evidence base here is robust. The key publications to reference are from the FLOW program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
39 1chris_chi24, tampaLisa73, KarenAZ_mom and 36 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register